English  |  正體中文  |  简体中文  |  2828323  
???header.visitor??? :  32242779    ???header.onlineuser??? :  4232
???header.sponsordeclaration???
 		 
???search.scope??? ???search.advance???
臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)
???ui.leftmenu.abouttair???
???ui.leftmenu.explanation???

???ui.leftmenu.bartitle???
Repositories
Author
Title
Date
???ui.leftmenu.statisticschart???
???ui.leftmenu.realtimefacts???
???ui.leftmenu.trend???

???index.news???
2019臺灣學術機構典藏
研討會
機構典藏系統RC7版本已
發佈

???ui.leftmenu.copyrighttitle???
???ui.leftmenu.copyrightpublisher???
???ui.leftmenu.copyrightconference???

???ui.leftmenu.link???
機構典藏計畫網站
ROAR
OpenDOAR
SHERPA
OAIster
JAIRO
Ira
DSPACE
RWWR
臺大學術典藏NTU Scholars
???tair.name??? >  ???browser.page.title.author???

"| liu c j"???jsp.browse.items-by-author.description???

???jsp.browse.items-by-author.back???
???jsp.browse.items-by-author.order1??? ???jsp.browse.items-by-author.order2???

Showing items 21-45 of 60  (3 Page(s) Totally)
1 2 3 > >>
View [10|25|50] records per page

Institution Date Title Author
臺大學術典藏 2021-07-12T02:44:41Z Sorafenib and its derivative SC-1 exhibit antifibrotic effects through signal transducer and activator of transcription 3 inhibition Su T.-H; | Shiau C.-W; | Jao P; | Liu C.-H; | Liu C.-J; | Tai W.-T; | Jeng Y.-M; | HUNG-CHIH YANG; | Tseng T.-C; | Huang H.-P; | Cheng H.-R; | Chen P.-J; | Chen K.-F; | Kao J.-H; | Chen D.-S.
臺大學術典藏 2021-07-12T02:44:40Z Peginterferon alfa-2a plus Weight-Based or Flat-Dose Ribavirin for Treatment-Na?ve Hepatitis C Virus Genotype 2 Rapid Responders: A Randomized Trial Liu C.-H; | Huang C.-F; | Liu C.-J; | Dai C.-Y; | Huang J.-F; | Lin J.-W; | Liang C.-C; | Yang S.-S; | Lin C.-L; | Su T.-H; | HUNG-CHIH YANG; | Chen P.-J; | Chen D.-S; | Chuang W.-L; | Kao J.-H; | Yu M.-L.
臺大學術典藏 2021-07-12T02:44:40Z Peginterferon alfa-2a with or without low-dose ribavirin for treatment-naive patients with hepatitis C virus genotype 2 receiving haemodialysis: A randomised trial Liu C.-H; | Liu C.-J; | Huang C.-F; | Lin J.-W; | Dai C.-Y; | Liang C.-C; | Huang J.-F; | Hung P.-H; | Tsai H.-B; | Tsai M.-K; | Lee C.-Y; | Chen S.-I; | Yang S.-S; | Su T.-H; | HUNG-CHIH YANG; | Chen P.-J; | Chen D.-S; | Chuang W.-L; | Yu M.-L; | Kao J.-H.
臺大學術典藏 2021-07-12T02:44:39Z Peginterferon plus Ribavirin for HIV-infected Patients with Treatment-Naive Acute or Chronic HCV Infection in Taiwan: A Prospective Cohort Study Liu C.-H; | Sheng W.-H; | Sun H.-Y; | Hsieh S.-M; | Lo Y.-C; | Liu C.-J; | Su T.-H; | HUNG-CHIH YANG; | Liu W.-C; | Chen P.-J; | Chen D.-S; | Hung C.-C; | Kao J.-H.
臺大學術典藏 2021-07-12T02:44:38Z Hepatitis B surface antigen loss and hepatocellular carcinoma development in patients with dual hepatitis B and C infection Yang W.-T; | Wu L.-W; | Tseng T.-C; | Chen C.-L; | HUNG-CHIH YANG; | Su T.-H; | Wang C.-C; | Kuo S.F.-T; | Liu C.-H; | Chen P.-J; | Chen D.-S; | Liu C.-J; | Kao J.-H.
臺大學術典藏 2021-07-12T02:44:38Z Hepatitis C viral infection increases the risk of lymphoid-neoplasms: A population-based cohort study Su T.-H; | Liu C.-J; | Tseng T.-C; | Chou S.-W; | Liu C.-H; | HUNG-CHIH YANG; | Wu S.-J; | Chen P.-J; | Chen D.-S; | Chen C.-L; | Kao J.-H.
臺大學術典藏 2021-07-12T02:44:37Z Viral Factors Affecting the Clinical Outcomes of Chronic Hepatitis B HUNG-CHIH YANG; | Shih Y.-F; | Liu C.-J.
臺大學術典藏 2021-07-12T02:44:36Z Fibrosis-4 Index Helps Identify HBV Carriers with the Lowest Risk of Hepatocellular Carcinoma Tseng T.-C; | Liu C.-J; | Su T.-H; | Yang W.-T; | Chen C.-L; | HUNG-CHIH YANG; | Wang C.-C; | Kuo S.F.-T; | Liu C.-H; | Chen P.-J; | Chen D.-S; | Kao J.-H.
臺大學術典藏 2021-07-12T02:44:36Z Hepatitis B virus reactivation in patients receiving interferon-free direct-acting antiviral agents for chronic hepatitis C virus infection Liu C.-H; | Liu C.-J; | Su T.-H; | Fang Y.-J; | HUNG-CHIH YANG; | Chen P.-J; | Chen D.-S; | Kao J.-H.
臺大學術典藏 2021-07-12T02:44:35Z Src-homology protein tyrosine phosphatase-1 agonist, SC-43, reduces liver fibrosis Su T.-H; | Shiau C.-W; | Jao P; | Yang N.-J; | Tai W.-T; | Liu C.-J; | Tseng T.-C; | HUNG-CHIH YANG; | Liu C.-H; | Huang K.-W; | Hu T.-C; | Huang Y.-J; | Wu Y.-M; | Chen L.-J; | Chen P.-J; | Chen D.-S; | Chen K.-F; | Kao J.-H.
臺大學術典藏 2021-07-12T02:44:35Z Clinical Efficacy and Post-Treatment Seromarkers Associated with the Risk of Hepatocellular Carcinoma among Chronic Hepatitis C Patients Lee M.-H; | Huang C.-F; | Lai H.-C; | Lin C.-Y; | Dai C.-Y; | Liu C.-J; | Wang J.-H; | Huang J.-F; | Su W.-P; | HUNG-CHIH YANG; | Kee K.-M; | Yeh M.-L; | Chuang P.-H; | Hsu S.-J; | Huang C.-I; | Kao J.-T; | Chen C.-C; | Chen S.-H; | Jeng W.-J; | Yang H.-I; | Yuan Y; | Lu S.-N; | Sheen I.-S; | Liu C.-H; | Peng C.-Y; | Kao J.-H; | Yu M.-L; | Chuang W.-L; | Chen C.-J.
臺大學術典藏 2021-07-12T02:44:34Z A noninvasive diagnosis of hepatic fibrosis by BioFibroScore? in chronic hepatitis C patients Liu C.-H; | Liu C.-J; | Hong C.-M; | Su T.-H; | HUNG-CHIH YANG; | Chen K.-M; | Huang Y.-P; | Yeh Y.-M; | Tien H.-L; | Liu Y.-C; | Kao J.-H; | Chen D.-S; | Chen P.-J.
臺大學術典藏 2021-07-12T02:44:33Z Distinct Relapse Rates and Risk Predictors after Discontinuing Tenofovir and Entecavir Therapy Su T.-H; | HUNG-CHIH YANG; | Tseng T.-C; | Liou J.-M; | Liu C.-H; | Chen C.-L; | Chen P.-J; | Chen D.-S; | Liu C.-J; | Kao J.-H.
臺大學術典藏 2021-07-12T02:44:33Z Real-world effectiveness and safety of paritaprevir/ritonavir, ombitasvir, and dasabuvir with or without ribavirin for patients with chronic hepatitis C virus genotype 1b infection in Taiwan Liu C.-H; | Liu C.-J; | Su T.-H; | HUNG-CHIH YANG; | Hong C.-M; | Tseng T.-C; | Chen P.-J; | Chen D.-S; | Kao J.-H.
臺大學術典藏 2021-07-12T02:44:33Z Sofosbuvir-based Interferon-Free Direct Acting Antiviral Regimens for Heart Transplant Recipients with Chronic Hepatitis C Virus Infection Liu C.-H; | Chen Y.-S; | Wang S.-S; | Liu C.-J; | Su T.-H; | HUNG-CHIH YANG; | Hong C.-M; | Chen P.-J; | Chen D.-S; | Kao J.-H.
臺大學術典藏 2021-07-12T02:44:32Z Generic velpatasvir plus sofosbuvir for hepatitis C virus infection in patients with or without human immunodeficiency virus coinfection Liu C.-H; | Sun H.-Y; | Liu C.-J; | Sheng W.-H; | Hsieh S.-M; | Lo Y.-C; | Liu W.-C; | Su T.-H; | HUNG-CHIH YANG; | Hong C.-M; | Tseng T.-C; | Chen P.-J; | Chen D.-S; | Hung C.-C; | Kao J.-H.
臺大學術典藏 2021-07-12T02:44:32Z Fibrosis-4 index predicts cirrhosis risk and liver-related mortality in 2075 patients with chronic HBV infection Tseng T.-C; | Liu C.-J; | Su T.-H; | Yang W.-T; | Chen C.-L; | HUNG-CHIH YANG; | Kuo S.F.-T; | Liu C.-H; | Chen P.-J; | Chen D.-S; | Kao J.-H.
臺大學術典藏 2021-07-12T02:44:31Z Acoustic radiation force impulse US imaging: Liver stiffness in patients with chronic hepatitis B with and without antiviral therapy Su T.-H; | Liao C.-H; | Liu C.-H; | Huang K.-W; | Tseng T.-C; | HUNG-CHIH YANG; | Liu C.-J; | Chen P.-J; | Chen D.-S; | Kao J.-H.
臺大學術典藏 2021-07-12T02:44:30Z Significance of definitions of relapse after discontinuation of oral antivirals in HBeAg-negative chronic hepatitis B Papatheodoridis G.V; | Manolakopoulos S; | Su T.-H; | Siakavellas S; | Liu C.-J; | Kourikou A; | HUNG-CHIH YANG; | Kao J.-H.
臺大學術典藏 2021-07-12T02:44:30Z Generic sofosbuvir-based interferon-free direct acting antiviral agents for patients with chronic hepatitis C virus infection: a real-world multicenter observational study Liu C.-H; | Huang Y.-J; | Yang S.-S; | Chang C.-H; | Yang S.-S; | Sun H.-Y; | Liu C.-J; | Liu W.-C; | Su T.-H; | HUNG-CHIH YANG; | Hong C.-M; | Tseng T.-C; | Chen P.-J; | Chen D.-S; | Hung C.-C; | Kao J.-H.
臺大學術典藏 2021-07-12T02:44:29Z Early antiviral therapy reduces the risk of lymphoma in patients with chronic hepatitis C infection Su T.-H; | Liu C.-J; | Tseng T.-C; | Chou S.-W; | Liu C.-H; | HUNG-CHIH YANG; | Wu S.-J; | Chen P.-J; | Chen D.-S; | Chen C.-L; | Kao J.-H.
臺大學術典藏 2021-07-12T02:44:29Z Real-world effectiveness and safety of sofosbuvir and ledipasvir with or without ribavirin for patients with hepatitis C virus genotype 1 infection in Taiwan Liu C.-H; | Liu C.-J; | Su T.-H; | HUNG-CHIH YANG; | Hong C.-M; | Tseng T.-C; | Chen P.-J; | Chen D.-S; | Kao J.-H.
臺大學術典藏 2021-07-12T02:44:28Z Chronic hepatitis B is associated with an increased risk of B-cell non-Hodgkin's lymphoma and multiple myeloma Su T.-H; | Liu C.-J; | Tseng T.-C; | Chou S.-W; | Liu C.-H; | HUNG-CHIH YANG; | Wu S.-J; | Chen P.-J; | Chen D.-S; | Chen C.-L; | Kao J.-H.
臺大學術典藏 2021-07-12T02:44:27Z Paritaprevir/ritonavir, ombitasvir plus dasabuvir for East Asian non-cirrhotic hepatitis C virus genotype 1b patients receiving hemodialysis Liu C.-H; | Shih Y.-L; | Yang S.-S; | Lin C.-L; | Fang Y.-J; | Cheng P.-N; | Chen C.-Y; | Peng C.-Y; | Hsieh T.-Y; | Chiu Y.-C; | Su T.-H; | Liu C.-J; | HUNG-CHIH YANG; | Chen P.-J; | Chen D.-S; | Kao J.-H.
臺大學術典藏 2021-07-12T02:44:27Z Sofosbuvir-based direct acting antiviral therapies for patients with hepatitis C virus genotype 2 infection Liu C.-H; | Su T.-H; | Liu C.-J; | Hong C.-M; | HUNG-CHIH YANG; | Tseng T.-C; | Chen P.-J; | Chen D.-S; | Kao J.-H.

Showing items 21-45 of 60  (3 Page(s) Totally)
1 2 3 > >>
View [10|25|50] records per page

DSpace Software Copyright © 2002-2004  MIT   &  Hewlett-Packard   /   Enhanced by   NTU Library IR team